Pediatric hospital care quality linked to patient population

Pediatric hospital care quality linked to patient population
The quality of pediatric hospital care is associated with whether the patients have severe and chronic conditions, not the financial resources of the hospital, according to a study published online Jan. 6 in Pediatrics.

(HealthDay)—The quality of pediatric hospital care is associated with whether the patients have severe and chronic conditions, not the financial resources of the hospital, according to a study published online Jan. 6 in Pediatrics.

To assess whether pediatric inpatient safety was associated with scarce hospital resources or with more severe and of the patient population, Linda Dynan, Ph.D., from the Cincinnati Children's Hospital Medical Center, and colleagues analyzed non-newborn pediatric inpatient hospital discharge records for 1,050 hospitals in 44 states in 2009 that met the criteria for potentially experiencing at least one pediatric quality indicator (PDI) event.

The researchers found that scarce resources, as assessed by high burden, were not associated with the number of pediatric discharges with one or more PDI event. In contrast, PDI events were strongly predicted by illness severity (adjusted odds ratio high relative to low, 15.12) and the presence of chronic conditions in the population (adjusted odds ratio one relative to zero conditions, 1.78; relative to two or more conditions, 3.38).

"Our findings suggest that the patient population served, rather than hospital category, best predicts measured quality, underscoring the need for robust risk adjustment when incentivizing quality or comparing hospitals," Dynan and colleagues conclude. "Thus, problems of quality may not be systemic across categories."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Virus drugmaker fights pediatricians' new advice

Jul 28, 2014

(AP)—A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the leading U.S. pediatrician's group, which recommends scaling back use of the medicine.

User comments